Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Gross Profit | 1,070 | 370 | 1,170 | 920 | 11,770 |
| Operating Expenses | 5,560 | 4,280 | 4,480 | 4,710 | 6,390 |
| Operating Income | -5,560 | -4,280 | -4,480 | -4,710 | -6,390 |
| Pre-tax Income | -5,560 | -4,280 | -4,480 | -4,710 | -6,390 |
| Net Income Continuous | -4,780 | -3,800 | -3,930 | -4,710 | -4,240 |
| Net Income | $-4,780 | $-3,800 | $-3,930 | $-4,710 | $-4,240 |
| EBITDA(a) | $-4,320 | $-3,040 | $-3,330 | $-3,680 | $-5,320 |